Japanese drug maker Daichii Sankyo, which has signed a share purchase agreement with Ranbaxy, on Thursday said its open offer for an additional 20 per cent stake in the domestic pharma major would undergo a change of schedule, pursuant to a delay in Sebi's approval.
The Competition Commission of India and the US Federal Trade Commission are yet to give their nod to the biggest pharma merger and acquisition deal this year in the Asia-Pacific region.
Aneesh Phadnis and Veena Mani find out what the manufacturers and the hospitals have to say.
A summary of sports events and persons in the news on Saturday.
Isinbayeva was under pressure to quit as head of RUSADA's supervisory council after the World Anti-Doping Agency (WADA) called for her removal, one of four steps it said were necessary for RUSADA to retrieve its right to oversee the testing of Russian athletes.
Virtual currencies don't have any intrinsic value and are not backed by any kind of assets.
'And that means all of us have to be very careful.'
Summary of sports events and persons who made news on Thursday
Uttar Pradesh Food and Drug Authority (FDA) says it has found excess lead in the Yippee noodles of domestic giant ITC.
The plant and associated facilities focus on manufacturing or packaging Amoxicilin-based products, which include semi-synthetic penicillin
On her maiden visit to India, US Food and Drug Administrator Margaret A Hamburg has said recent lapses in quality by a handful of pharma companies has overshadowed the good things done by other Indian companies, who emphasise on quality products and practices.
Experts believe market launches can now happen seamlessly and quickly if FSSAI is removed from the process.
In the broader markets, BSE Midcap index slipped 0.3% whereas the BSE Smallcap index inched up by 0.2%
Companies that are developing biosimilars (for regulated markets) or have portfolio of new chemical entities (NCEs) under development.
Nestle refused to regret the mistake in a public statement.
The growth prospects are particularly high for Indian companies in the speciality and complex generic drugs segment in the US, the report said.
The allocation for health ministry for 2017-18 is Rs 47,352.51 crore in comparison to allocation in 2016-17 of Rs 37,061.55 crore.
Domestic firms Aurobindo Pharma, Glenmark Pharmaceuticals and Natco Pharma have received US health regulator's approval to market their generic Rizatriptan Benzoate orally disintegrating tablets used for treating migraine in the American market.
The Cabinet Committee on Economic Affairs has approved the proposal of GlaxoSmithKline Pte Limited, Singapore for acquisition of 24.33 per cent shares in existing Indian subsidiary company of GSK Group.
Global generic drugs producer Sandoz has opened its third plant in India at Navi Mumbai with annual production capacity of one billion tablets and capsules.
People close to Shanghvi reveal he is known to make surprising moves both inside and outside the pharma industry.
'The government is abdicating its responsibility on healthcare.' 'Just to start this scheme, it will take a minimum till October 2018 and elections are coming in 2019, so before that this can go into the dustbin.'
Maggi noodles was recalled in June because some states had found presence of MSG and excessive lead content in the samples.
Ranbaxy, which is 63.5 per cent-owned by Japan's Daiichi Sankyo Co and gets more than 40 per cent of its sales from the United States, did not immediately respond to a request on Wednesday for comment on the FDA observations.
As many as 11 industry bodies related to food and pharma sectors on Thursday alleged that the food regulator FSSAI has become "den of corruption" and demanded a CBI inquiry into the functioning of the authority, which shot to limelight over the Maggi issue.
'When there is unlocking, there is demand revival.' 'This is going to be the main growth engine in this kind of an economic scenario.'
Bankers pay a small price for their misdeeds, no matter how large the cost to their banks or to the economy at large, says TT Ram Mohan.
This is second time in a month when a packaged food co has complained
Business of retail, food and beverages at duty-free shops in India was estimated to have a potential of $3.5 billion by 2021.
The deal was, however, dismissed by the Democrats as a 'non-starter'.
A day after death toll due to swine flu crossed 700, Union Minister of State for Health Shripad Naik said the Centre is sending special ayurvedic medicinal syrups to all states as part of its efforts to combat the influenza.
Whatever the outcome of the assembly election in Rajasthan, Ashok Gehlot is firmly ensconced in the Congress inner circle.
Ranbaxy Laboratories edged higher on Tuesday following reports that the company has received the regulators nod to market a new drug in the US.
The growth has slowed down with exports at $6.7 billion last year.
Investors will maintain a cautious stance.
